NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.65
-0.30 (-0.83%)
Dec 24, 2025, 1:00 PM EST - Market closed
NAMS Employees
NewAmsterdam Pharma Company had 68 employees as of December 31, 2024. The number of employees increased by 39 or 134.48% compared to the previous year.
Employees
68
Change (1Y)
39
Growth (1Y)
134.48%
Revenue / Employee
$518,279
Profits / Employee
-$3,251,074
Market Cap
4.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAMS News
- 19 days ago - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - NewAmsterdam Pharma Company N.V. (NAMS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December - GlobeNewsWire
- 5 weeks ago - NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating - Seeking Alpha
- 7 weeks ago - NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in November - GlobeNewsWire
- 3 months ago - NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewsWire
- 4 months ago - NewAmsterdam Pharma Company N.V. (NAMS) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha